In Assam, the story of Anika Khanum, a 12‑year‑old girl from Kayakuchi, highlights the systemic challenges in diagnosing and treating childhood tuberculosis in India.
Key Developments
- December 2025 – Anika develops cough and high fever; first private doctor misdiagnoses her with typhoid.
- January 2026 – Second private doctor gives antibiotics; no improvement.
- February 2026 – Barpeta District Hospital X‑ray reveals TB signs.
- March 2026 – Sputum test confirms drug‑resistant TB; treatment with levofloxacin is started.
- May 2026 – Fever subsides; Anika begins to recover.
Important Facts
India accounts for 3.3–3.4 lakh childhood TB cases annually, about 28 % of the global total, yet only 6 % are reported to the NTEP. The average patient consults two to three providers before a correct diagnosis; for children, the delay is often longer.
Typical pediatric symptoms are vague – weight loss, poor appetite, or mild cough – making clinical suspicion difficult. Stigma forces families to hop between doctors, losing valuable weeks.
Diagnostic hurdles include the inability of young children to produce sputum. Alternatives such as bronchoscopy or gastric aspirates are invasive, technically demanding, and often declined by parents.
When microbiological confirmation is unavailable, clinicians rely on chest X‑rays or Mantoux testing, which can lead to empirical treatment and uncertainty about drug resistance.
Exam Relevance
Understanding childhood TB touches upon multiple GS papers:
- GS1 (Health): Epidemiology of TB, burden in children, and public‑health impact.
- GS2 (Polity): Role of central and state health ministries, NTEP governance, and private‑sector engagement.
- GS3 (Economy): Economic loss due to missed school, productivity, and cost of drug‑re